Amgen, Inc.
NASDAQ:AMGN
$69.17
$0.05
(0.07%)
Quote as of 4:00 PM EST on 02/07/12
|
$69.17
$0.05
(0.07%)
|
|
| Today's Open | $68.71 |
|---|---|
| Previous Close | $69.12 |
| Daily Range | $68.15 - $69.24 |
| 52-Week Range | $47.66 - $70.00 |
| Market Cap | $60.63B |
| P/E Ratio | 12.97 |
| Dividend (Yield) | $1.44 (2.1%) |
| Ex-Dividend Date Dividend Pay Date |
02/13/12 03/07/12 |
| Volume | 6,870,447 |
| Average Daily Volume | 6,558,413 |
| Current FY EPS | $5.96 |
AMGN Information
| Description |
|---|
| A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Can Amgen Convince Docs to Recommend Approval?
FDA Questions Benefit Of Amgen Bone Drug In Certain Cases
WSJ BLOG/Health: FDA Questions Benefit of Amgen Bone Drug in Certain Cases
Amgen Cancer Drug Xgeva Faces Scrutiny for New Use
How Many Stocks Should You Own? - Investment Ideas
Has Amgen Become the Perfect Stock?
Amgen, Vivus, Chelsea Therapeutics Prep for Key Catalysts in February
UPDATE: Pacific Rubiales Lists Depositary Receipts In Brazil
UPDATE: Pfizer 4Q Profit Slumps 50% As Lipitor Sales Decline
